Syneron to Participate in Three Upcoming Investor Conferences

Syneron to Participate in Three Upcoming Investor Conferences:

Brean Murray, Carret & Co. Life Sciences Summit
Date: Monday, November 14, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Lazard Capital Markets 8th Annual Healthcare Conference
Date and Time: 2:30 pm ET on Wednesday, November 16, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Leerink Swann Healthcare Management Access Day
Date: Monday, November 21, 2011
Syneron Participant: Louis P. Scafuri, Chief Executive Officer 

 

Read More

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron®'s signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron® products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.